C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 233/61 (2006.01) A61K 31/395 (2006.01) C07C 311/17 (2006.01) C07D 215/36 (2006.01) C07D 233/54 (2006.01) C07D 233/68 (2006.01) C07D 233/91 (2006.01) C07D 239/36 (2006.01) C07D 239/80 (2006.01) C07D 249/08 (2006.01) C07D 403/12 (2006.01) C07D 471/04 (2006.01) C07D 473/00 (2006.01) C07D 473/40 (2006.01) C07D 487/04 (2006.01) C07D 495/04 (2006.01) C07D 521/00 (2006.01) C07F 7/18 (2006.01)
Patent
CA 2127367
2127367 9314069 PCTABS00024 Compounds of formula (I), wherein: A represents: a) a -VR6 group wherein v is -C(=O)-, -C(=O)O-, -CH2O-, -CH2OC(=O)-, -C(=S)-, -CH2OC(=O)NH-, -C(=S)O-, -CH2S-, -C(=O)NHSO2-, -SO2NHC(=O)- or -CH2OSiPh2-; b) a -CH2NR9R10 group or a -CONR9R10 group wherein each of R9 and R10 is independently hydrogen, -alkyl-, -alkenyl-, -alkynyl, -cycloalkyl, -cycloalkenyl, pyridyl (any of which may optionally be substituted) or a group -D as defined above or R9 and R10 together with the nitrogen atom to which they are attached form a nitrogen-containing heterocyclic ring; c) a group Y where Y is a 5- or 6-membered optionally substituted heterocyclic ring containing one or more heteroatoms selected from nitrogen, oxygen and sulphur; or d) a group -CH2-Y or -C(=O)NHY; where Y is as defined above; B represents: a 5- or 6-membered heterocyclic ring containing one or more nitrogen atoms in its ring, are antagonists of platelet activating factor (PAF) and/or antagonists of angiotensin II.
Bowles Stephen Arthur
Floyd Christopher David
Miller Andrew
Whittaker Mark
Wood Lars Michael
British Bio-Technology Limited
Gowling Lafleur Henderson Llp
LandOfFree
Heterocyclic sulfonamide derivatives as antagonists of paf... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic sulfonamide derivatives as antagonists of paf..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic sulfonamide derivatives as antagonists of paf... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1862880